Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States
PaperCitations, authors & open-access status
Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 14 citations, 2018 year and closed oa status.
14
Citations
2018
Year
closed
OA Status